Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

SGN-00101

A recombinant chimeric protein composed of the heat shock protein 65 (Hsp65) from Mycobacterium bovis, and the human papilloma viral (HPV) protein E7… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
OBJECTIVE Approximately 2 million women worldwide are infected with high-risk human papillomaviruses (HPV), resulting in a… Expand
Is this relevant?
Highly Cited
2007
Highly Cited
2007
OBJECTIVES SGN-00101 (HspE7, Nventa, San Diego, CA) is a novel therapeutic vaccine consisting of a fusion protein containing an M… Expand
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Objectives:To test a therapeutic vaccine consisting of a fusion of the human papillomavirus (HPV) 16 E7 protein and the… Expand
Is this relevant?
2001
2001
  • S Hunt
  • Current opinion in molecular therapeutics
  • 2001
  • Corpus ID: 40214286
StressGen is developing HspE7 (SGN-00101) as a potential therapy for human papillomavirus (HPV)-associated conditions. It is a… Expand
Is this relevant?